Winrevair, sotatercept-csrk 60MG/vial INJ, lyphl NDC: 00006-5091-01
Ended Awarded
- Contract number
- 36C26126N0291
- Awardee
-
Merck Sharp & Dohme LLC UEI FCFDA78HKKG2
- Awarding agency
-
Veterans Integrated Service Network 21
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $96,218
Award facts
- Contract value 100% obligated
- $96,218.46 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Rahway, NJ 07065, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 21, awarded a delivery order to Merck Sharp & Dohme LLC for the supply of WINREVAIR (sotatercept-csrk) 60 mg/vial injectable, lyophilized pharmaceutical product under a firm fixed-price contract valued at $96,218.46. The award, issued on January 13, 2026, with an ultimate completion date of October 13, 2026, represents a child contract under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). No set-aside designation was utilized in this competitive procurement, reflecting open competition among qualified pharmaceutical suppliers.
Merck, headquartered in Rahway, New Jersey—the location of performance for this delivery order—is an established federal pharmaceutical supplier with a robust portfolio of government contracts spanning multiple agencies including the Department of Veterans Affairs, Centers for Disease Control and Prevention, and Department of Health and Human Services. The company maintains significant indefinite delivery vehicles, including a $5.8 billion Federal Supply Schedule contract with the Department of Veterans Affairs for pharmaceuticals and related products, from which this delivery order is issued. WINREVAIR is a specialized pharmaceutical treatment used in federal healthcare programs, and this award ensures continued availability of the medication to support VA patient care initiatives.
Quick answers
Who was awarded contract 36C26126N0291?
36C26126N0291 was awarded to Merck Sharp & Dohme LLC by Veterans Integrated Service Network 21 (Veterans Health Administration) on January 13, 2026.
How much is contract 36C26126N0291 worth?
The government has obligated $96,218 on 36C26126N0291.
Is contract 36C26126N0291 an order under another contract?
Yes. 36C26126N0291 is a delivery order under 36F79725D0146, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26126N0291 competed?
The extent of competition for 36C26126N0291 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award